Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

clinical_trial-web

Promising results for new type 2 diabetes management procedure

August 12, 2016 Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes

Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …
News

Ashfield publishes a guide to Patient Support Programmes: Ten steps to success

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …
News
Press release
allergan

Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016 Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …
News
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …
News
astrazeneca_building_white

Thousands to benefit with new anti-clotting drug recommendation, says NICE

August 12, 2016 Medical Communications, Sales and Marketing AstraZeneca, Brilique, ticagrelor

The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending AstraZeneca’s Brilique (ticagrelor) for people …
News
shutterstock_92671375

Valeant under criminal investigation

August 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation

Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …
News

FDA accepts Marathon’s Duchenne drug for priority review

August 11, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals

Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …
News
chemo-web

Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug

August 11, 2016 Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol

Heron Therapeutics has announced that it has received US Food and Drug Administration (FDA) approval for Sustol (granisetron) for the …
News
chronos_therapeutics

Chronos Therapetics strengthens management with two new vice presidents

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …
Appointment
josh-smiley

New senior VP, finance at Eli Lilly

August 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …
Appointment
china-pharmaceutical-industry

New Agilent expansion will ‘more than double’ nucleic acid API manufacture

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide

Agilent Technologies is set to expand its pharmaceutical manufacturing operations with a 20-acre facility in Weld County, Colorado. The facility …
News
shutterstock_138095450

Valeant stock rises despite weak Q2 results

August 10, 2016 Research and Development, Sales and Marketing Valeant, financial results

Valeant Pharmaceuticals’ share price in pre-market trading has risen 7.44% to $24.12 in the wake of its Q2 results announcement. …
News
biogen_austria_238

Biogen names haemophilia spin-off Bioverativ

August 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, bioverativ

Biogen has announced that Bioverativ will be the name of the standalone spin-off of its haemophilia and other blood disorders …
News
takeda_tokyo_hq

Old CDF drug not recommended in initial NICE guidance due to lack of evidence

August 10, 2016 Research and Development, Sales and Marketing Adcetris, Cancer Drugs Fund, NICE, Takeda, hodgkin's lymphoma

The National Institute for Health and Care Excellence (NICE) has published draft guidance not recommending Takeda’s Adectris (brentuximab vedotin), despite …
News
imlygic_amgen

NICE recommends Amgen’s Imlygic for advanced skin cancer

August 9, 2016 Manufacturing and Production, Sales and Marketing Amgen, Imlygic, NICE, skin cancer

NICE has published its final draft guidance recommending Amgen’s Imlygic (talimogene laherparepvec) for the treatment of advanced melanoma in adults …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026